Rare diseases
Investigational molecules
Locations
Back to Germany41 clinical trials in Amberg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
GermanyGermanyStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
GermanyEfficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes
GermanyStudy of precemtabart tocentecan alone or in drug combination versus standard therapy in previously treated metastatic colorectal cancer patients
GermanyMaintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer
GermanyStudy of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer
GermanyA Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment
GermanyA study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
GermanyGermanyStudy on Fruquintinib and Tislelizumab for Patients with Metastatic Colorectal Cancer Without Liver Metastases
GermanyStudy of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on colorectal cancer treatments, including studies of novel drug combinations and targeted therapies for metastatic disease. Research encompasses both early-stage interventions and advanced treatment protocols.
Multiple trials evaluating immunotherapy combinations and precision medicine approaches for various cancer types.
Innovative research in chronic lymphocytic leukemia and lymphoma, investigating novel therapeutic combinations and targeted treatments for better patient outcomes.
Focus on personalized treatment approaches and duration optimization based on minimal residual disease monitoring.
Studies examining new treatments for hypercholesterolemia and investigating innovative approaches to cardiovascular disease management.
Trials evaluating combination therapies and novel compounds for metabolic disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
